Glycologix
BEVERLY, MA · Biotechnology, Information Technology · 8 employees
Glycologix Inc. is an emerging biotechnology company targeting locally delivered biopolymers for the protection of soft tissues. Multiple unmet medical conditions can be addressed by replenishment of naturally occurring proteoglycans. Our platform discovery engine enables the preparation of synthetic structural mimics of proteoglycans. Despite their high molecular weight, these novel materials are
Funding history
- Funding Round — $800K — Dec 2025
- Series seed — $1.5M — Apr 2024
- Series seed — $1.1M — May 2023
- Funding Round — $1.8M — Jan 2022
Recent signals
- Dec 29, 2025: Raised $800K
- Apr 09, 2024: Raised $1.5M in Series seed
- May 23, 2023: Raised $1.1M in Series seed
- Jan 10, 2022: Raised $1.8M
See plans & pricing → Track Glycologix’s funding, hiring, and signals — with verified contacts — on Fundz.